Zochodne Douglas W
Department of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta T2N 4N1, Canada.
Muscle Nerve. 2007 Aug;36(2):144-66. doi: 10.1002/mus.20785.
Diabetes targets the peripheral nervous system with several different patterns of damage and several mechanisms of disease. Diabetic polyneuropathy (DPN) is a common disorder involving a large proportion of diabetic patients, yet its pathophysiology is controversial. Mechanisms considered have included polyol flux, microangiopathy, oxidative stress, abnormal signaling from advanced glycation endproducts and growth factor deficiency. Although some clinical trials have demonstrated modest benefits in disease stabilization or pain therapy in DPN, robust therapy capable of reversing the disease is unavailable. In this review, general aspects of DPN and other diabetic neuropathies are examined, including a summary of recent therapeutic trials. A particular emphasis is placed on the evidence that the neurobiology of DPN reflects a unique yet common and disabling neurodegenerative disorder.
糖尿病通过几种不同的损伤模式和多种疾病机制影响周围神经系统。糖尿病性多发性神经病(DPN)是一种常见疾病,累及很大比例的糖尿病患者,但其病理生理学仍存在争议。已被考虑的机制包括多元醇通量、微血管病变、氧化应激、晚期糖基化终产物的异常信号传导和生长因子缺乏。尽管一些临床试验已证明在DPN的疾病稳定或疼痛治疗方面有一定益处,但尚无能够逆转该疾病的有效疗法。在本综述中,我们研究了DPN和其他糖尿病性神经病变的一般情况,包括近期治疗试验的总结。特别强调的是,有证据表明DPN的神经生物学反映了一种独特但常见且致残的神经退行性疾病。